Inve US ▾
AMAME

AMETEK (AME) Q2 FY26 earnings call: guidance and Q&A

Earnings call· Jun 2026 (Q2 FY26)· Industrials· Aug 4, 2026

Source: earnings call transcript

Executive summary

AMETEK Q2 FY26 — Record Performance Driven by Strong Orders and Secular Tailwinds

AMETEK delivered an outstanding second quarter, exceeding expectations with record sales, orders, and earnings, driven by broad-based organic growth and robust margin expansion. The company's strategic portfolio alignment with secular growth drivers like AI infrastructure, defense modernization, and medtech is fueling strong demand. Management raised full-year guidance, reflecting confidence in continued performance and a strong pipeline of acquisition opportunities.

Highlights

5
  • Record sales of $2.04 billion, up 15% year-over-year (10% organic).

  • Record orders of $2.3 billion, up 28% year-over-year (25% organic), leading to a record backlog of $4.1 billion.

  • Record diluted earnings per share of $2.09, up 17% year-over-year and above guidance.

  • Free cash flow up 37% to $452 million, with a strong 111% conversion rate.

  • Core operating margins expanded by 110 basis points to 27.1%.

Guidance & targets

CategoryTargetConfidence
Full-year 2026 Overall Sales Growth
up approximately 10%
high materiality
High
Full-year 2026 Organic Sales Growth
up mid- to high single digits
high materiality
High
Full-year 2026 Diluted Earnings Per Share
$8.20 to $8.30
high materiality
High
Q3 2026 Overall Sales Growth
up high single digits
medium materiality
High
Q3 2026 Adjusted Earnings Per Share
$2.08 to $2.10
medium materiality
High
Full-year 2026 Effective Tax Rate
between 18.5% and 19%
low materiality
High
Full-year 2026 Capital Expenditures
approximately $160 million
medium materiality
High
Full-year 2026 Free Cash Flow Conversion
110% to 115% of net income
medium materiality
High
Full-year 2026 Process Segment Organic Sales Growth
up mid-single digits
medium materiality
High
Full-year 2026 Aerospace & Defense Organic Sales Growth
up low double digits
medium materiality
High
Full-year 2026 Power Businesses Organic Sales Growth
up mid-single digits
medium materiality
High
Full-year 2026 Automation & Engineered Solutions Organic Sales Growth
up high single digits
medium materiality
High

Segment performance

SegmentRevenueYoYQoQMargin
Electronic Instruments Group (EIG)
EIG generated outstanding results with broad-based growth across process instrumentation, aerospace, and power businesses. Strong positions in attractive markets drove both sales and orders.
Organic Sales Growth: 7%Acquisition Contribution to Sales Growth: 7%Foreign Currency Impact on Sales: flatOverall Orders Growth: 23%Organic Orders Growth: 20%Core Operating Margins: 30.1%Core Operating Margin Change: +40 bps
$1.32B14%—$385M
Electromechanical Group (EMG)
EMG delivered exceptional results with balanced sales growth across aerospace, defense, medtech, and automation businesses. Strong core margin expansion was driven by new product phasing and lean cost structure, particularly from Paragon Medical.
Organic Sales Growth: 15%Acquisition Contribution to Sales Growth: ~2%Organic Orders Growth: 35%Core Operating Margins: 26.2%Core Operating Margin Change: +290 bps
$723M17%—$191M
Process Businesses
Sales driven by recent acquisitions and excellent organic growth. Project activity remains strong, with particular strength in semiconductor and energy-related instrumentation.
Organic Sales Growth: high single-digitOrders: outstandingStrongest Growth Areas: semiconductor and energy-related instrumentation
—high teens——
Aerospace & Defense Businesses
Demand remains robust across all segments, benefiting from increased defense spending and the commercial aerospace super cycle.
Demand: robustStrongest Growth Areas: commercial OE and commercial aftermarket
—mid-teens organic——
Power Businesses
Delivered mid-single-digit organic sales growth with strong orders momentum supporting the broader power grid build-out.
Orders Momentum: strongPipeline: growing, in support of power grid build-out
—mid-single-digit organic——
Automation & Engineered Solutions
Outstanding organic growth, well-aligned with attractive growth applications in medtech, semiconductor, and automation.
Growth: excellent and broad-basedAlignment: attractive growth applications in medtech, semiconductor, and automation
—mid-teens organic——

AME operating KPIs by quarter

AME operating KPIs stated on its earnings calls, by fiscal quarter
KPI Dec 2024 Q4 FY24 Mar 2025 Q1 FY25 Sep 2025 Q3 FY25 Dec 2025 Q4 FY25 Mar 2026 Q1 FY26This call Jun 2026 Q2 FY26Change vs prior quarter
Backlog
$3.4B with positive organic growth across both our EIG and EMG segments, and we ended the quarter with a strong backlog of $3.4 billion. Source: earnings call transcript
$3.47B Book-to-bill in the quarter was 1.04, and we ended the first quarter with a backlog of $3.47 billion near record levels. Source: earnings call transcript
$3.54B Orders were also very strong in the quarter with overall orders up 13% to a record $1.97 billion and organic orders up 7%, leading to a record backlog of $3.54 billion. Source: earnings call transcript
$3.58B Orders were very strong in the quarter with overall orders up 18% to a record $2 billion and organic orders up 7% versus the prior year, leading to a record backlog of $3.58 billion. Source: earnings call transcript
$3.87B Overall, orders were a record $2.2 billion, up 23% versus the prior year organic orders were up 22%, leading to a record backlog of $3.87 billion. Source: earnings call transcript
—+8.1%
Book-to-bill ratio —
1.04 ratio Book-to-bill in the quarter was 1.04, and we ended the first quarter with a backlog of $3.47 billion near record levels. Source: earnings call transcript
—
1.02 ratio So it was broad-based, and there was a similar pattern from Q3 and the book-to-bill of AMETEK was 1.02, and it was pretty broad-based. Source: earnings call transcript
—
1.12 ratio Our backlog was now $4.11 billion, up about 21% from the end of the year, and we had a positive book-to-bill of 1.12 in the quarter, both groups positive -- and we also are executing very well. Source: earnings call transcript
—
Vitality Index —
26% Our vitality index, which measures the sales of new products introduced in the past 3 years was a strong 26% in the first quarter. Source: earnings call transcript
26% The tangible results of this focus are clear with our third quarter Vitality Index, a strong 26%. Source: earnings call transcript
30% In the fourth quarter, our Vitality Index, which measures sales of new products introduced over the last 3 years was an outstanding 30%. Source: earnings call transcript
25% In the first quarter, our vitality index which measures sales of new products introduced over the last 3 years was an outstanding 25%. Source: earnings call transcript
25% In the second quarter, our new product vitality was a strong 25%. Source: earnings call transcript
0 pt
Orders ——
$1.97B Orders were also very strong in the quarter with overall orders up 13% to a record $1.97 billion and organic orders up 7%, leading to a record backlog of $3.54 billion. Source: earnings call transcript
$2B Orders were very strong in the quarter with overall orders up 18% to a record $2 billion and organic orders up 7% versus the prior year, leading to a record backlog of $3.58 billion. Source: earnings call transcript
$2.2B Overall, orders were a record $2.2 billion, up 23% versus the prior year organic orders were up 22%, leading to a record backlog of $3.87 billion. Source: earnings call transcript
$2.3B Overall orders were a record $2.3 billion, up 28% versus the prior year, with organic orders up sharply at 25%, being to a record backlog of $4.1 billion. Source: earnings call transcript
+4.5%

Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.

Orderbook & backlog

Total Backlog $4.1B Q2 FY26

up 21% from end of year

~80% will ship within the next 12 months

Overall Orders $2.3B Q2 FY26

up 28% YoY

Organic orders up 25% YoY

Product announcements

ProductTypeDetails
Microfoillaunch
A2 GLF oxygen sensorlaunch

Deals & partnerships

Indoor Instrumentation (Indicor) Acquisition of a group of high-quality businesses with leading market positions in attractive niche markets, differentiated technologies, strong IP, and deep domain expertise. $5B

Teams are working through integration planning. The acquisition is expected to close in the second half of the year. Post-closing, AMETEK will retain substantial financial capacity ($2.5B cash and credit facilities).

Ferro Acquisition of a company that designs and develops advanced 3D metrology and digital reality solutions, complementing AMETEK's Creaform business.

Integration is on plan, and the teams are working well. It was an excellent strategic fit, putting together market leaders.

Undisclosed Renewal of committed revolving credit facility. $3.5B until June 2031

The size of the revolver facility increased to $3.5 billion, and the maturity was extended until June 2031. Positions the company well to support future growth initiatives.

What to watch in Q3 FY26

Indicor Acquisition Closing & Integration

H2 FY26
Current Integration planning underway, expected H2 FY26 close
Target Acquisition closed, integration progressing as planned

Why it matters

The $5 billion acquisition is a significant capital deployment and is expected to drive future growth and synergies.

We remain excited for the acquisition of Indoor Instrumentation. Our teams are working through the integration planning and we continue to expect the acquisition to close in the second half of the year.

Find out whether AME delivers this. Inve re-checks your case every morning.

Q&A highlights

Can you provide an update on end market and regional performance, and are you seeing positive inflection in the non-data center industrial economy, similar to ISM trends?

Dave Zapico provided a comprehensive overview of end market performance (Process, A&D, Power, Automation) and regional strength (US, Asia, Europe). He confirmed broadening growth beyond just AI, citing defense modernization, energy security, and commercial aerospace as multi-year infrastructure build-outs driving demand for AMETEK's mission-critical products.

“So when I look at this thing, we're really -- there's durability because the underlying capital spend our customers is driving a multiyear infrastructure build-out, and we are supplying mission-critical essential products for new semiconductor fabs, new power plants, the A&D market, defense modernization. So I believe we're in the beginning stages of a multiyear infrastructure built on, and we're incredibly well positioned.”

asked by Deane Dray · answered by David Zapico

2 min read 6 chapters

Detailed narrative

Exceptional Q2 Performance and Raised Outlook

AMETEK reported a record second quarter, surpassing expectations with double-digit organic sales growth, robust orders, and strong core margin expansion. This performance led to a significant increase in full-year sales and earnings guidance. The company's ability to execute across its diverse portfolio, coupled with disciplined operational management, positions it for continued growth through the remainder of the year.

Strategic Alignment with Secular Growth Drivers

The company highlighted its strategic alignment with powerful secular growth drivers, including AI infrastructure, defense modernization, and energy security. Businesses like RTDS and Zygo are directly benefiting from increased demand in data center power systems and advanced semiconductor manufacturing. This broad alignment across multiple thematic drivers provides durability and reduces dependence on any single market.

Key Business Unit Highlights and Innovation

Several business units demonstrated strong performance and innovation. Paragon Medical achieved outstanding growth driven by new design wins in orthopedics and drug delivery. The Used Trailer business introduced Microfoil, a next-generation lightweight heat exchanger for aerospace and defense. AlphaSense received the Innovation Award for its A2 GLF oxygen sensor, the world's first Galvanic lead-free oxygen sensor, designed for demanding environmental applications.

Robust Capital Deployment and Acquisition Strategy

AMETEK's strong balance sheet and consistent cash flow support its top capital deployment priority: strategic acquisitions. The company is progressing with the integration planning for the Indoor Instrumentation (Indicor) acquisition, expected to close in the second half of the year. Post-acquisition, AMETEK anticipates substantial financial capacity for further growth initiatives, reinforcing its commitment to portfolio expansion.

Internal AI Integration and Efficiency Gains

AMETEK is actively leveraging AI to enhance efficiency and accelerate growth across all functions, from speeding up due diligence and automating document processing to improving customer service and predicting supply delays. AI is also being integrated into product development, shortening design cycles and enhancing predictive maintenance capabilities, demonstrating a commitment to becoming an AI-enabled company.

Broad-Based End Market and Geographic Strength

Growth was broad-based across all major end markets and geographies. Process, Aerospace & Defense, Power, and Automation & Engineered Solutions segments all reported strong organic sales growth. Geographically, the U.S. and Asia were particularly strong, with Europe also contributing mid-single-digit growth, indicating widespread demand for AMETEK's mission-critical solutions.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.